Molecularly targeted cancer therapy: some lessons from the past decade

Min Huang,Aijun Shen,Jian Ding,Meiyu Geng
DOI: https://doi.org/10.1016/j.tips.2013.11.004
IF: 17.638
2014-01-01
Trends in Pharmacological Sciences
Abstract:The tremendous advances achieved in the understanding of cancer biology have delivered unprecedented progress in molecularly targeted cancer therapy in the past decade. The fast growing category of targeted anticancer agents available for clinical use is accompanied by a conceptual revolution in anticancer drug development. Nevertheless, molecularly targeted cancer therapy remains challenged by a high failure rate and an extremely small proportion of patients that can benefit. It is pivotal to take lessons from the past and seek new solutions. This review discusses conceptual progress and remaining challenges in molecularly targeted cancer therapy, and proposes feasible alternatives to increase chances of clinical success in the future.
pharmacology & pharmacy
What problem does this paper attempt to address?